Skip to content

Clinical trials

Phase 1/2 Sarcopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcopenia Phase: Phase 1/2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20141
20171
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center2
VA Office of Research and Development2
Anna Arthur, PhD1
ENCell1
GuangZhou Cellgenes Biotechnology Co., Ltd.1
Sara Espinoza1
University of Virginia1
Unlimited Biotechnology LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcopenia10
Atrophy2
Frailty2
Head and Neck Neoplasms1
Hypertrophy1
Insulin Resistance1
Muscle Weakness1
Muscular Atrophy1
Neoplasms1
Obesity1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.